Brief: Scynexis enters into controlled equity offering sales agreement
06/11/2024 21:27
Nov 6 (Reuters) - SCYNEXIS Inc SCYX.O :
* SCYNEXIS- ENTERED INTO CONTROLLED EQUITY OFFERING SALES
AGREEMENT, MAY OFFER & SELL SHARES OF COMMON STOCK FOR $50
MILLION FROM TIME TO TIME
Source text: ID:n0000950170-24-122273
Further company coverage: SCYX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview